Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Tandem Diabetes Care | TNDM | Mar 17, 2025 | 19.71 | +2.82 |
Tanger | SKT | Mar 17, 2025 | 32.40 | +1.41 |
Tango Therapeutics | TNGX | Mar 17, 2025 | 1.95 | 0.00 |
Tantech | TANH | Mar 17, 2025 | 2.76 | -4.66 |
Taoping | TAOP | Mar 17, 2025 | 0.29 | -1.84 |
Tapestry | TPR | Mar 17, 2025 | 71.22 | +1.08 |
Targa Resources | TRGP | Mar 17, 2025 | 196.60 | +3.31 |
Target | TGT | Mar 17, 2025 | 105.67 | +0.93 |
Target Hospitality | TH | Mar 17, 2025 | 5.71 | +0.26 |
Tarsus Pharmaceuticals | TARS | Mar 17, 2025 | 47.49 | -1.25 |
Taseko Mines | TGB | Mar 17, 2025 | 2.40 | +3.00 |
TaskUs A | TASK | Mar 17, 2025 | 13.46 | -1.54 |
TAT Technologies | TATT | Mar 17, 2025 | 26.09 | +1.16 |
Tavia Acquisition | TAVI | Mar 17, 2025 | 10.04 | 0.00 |
Tavia Acquisition Unit | TAVIU | Mar 17, 2025 | 10.24 | 0.00 |
Taylor Devices | TAYD | Mar 17, 2025 | 31.49 | +0.32 |
Taylor Morrison Home | TMHC | Mar 17, 2025 | 58.75 | +0.10 |
Taysha Gene Therapies | TSHA | Mar 17, 2025 | 1.79 | +4.07 |
TC Biopharm ADR | TCBP | Mar 17, 2025 | 1.75 | +1.16 |
TC Energy | TRP | Mar 17, 2025 | 47.75 | +1.34 |
TCTM Kids IT Education ADR | TCTM | Mar 17, 2025 | 0.37 | +2.49 |
TCW Strategic | TSI | Mar 17, 2025 | 4.87 | 0.00 |
TD Synnex | SNX | Mar 17, 2025 | 128.50 | +1.03 |
TDH Holdings | PETZ | Mar 17, 2025 | 1.37 | 0.00 |
TE Connectivity | TEL | Mar 17, 2025 | 146.74 | +0.59 |
Team | TISI | Mar 17, 2025 | 14.08 | +1.37 |
TechnipFMC Plc | FTI | Mar 17, 2025 | 28.27 | +3.78 |
Technology Alphadex First Trust | FXL | Mar 17, 2025 | 138.02 | +1.55 |
Technology Bear 3X Direxion | TECS | Mar 17, 2025 | 56.91 | -2.37 |
Technology Bull 3X Direxion | TECL | Mar 17, 2025 | 66.91 | +2.18 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.